US Patent Issued to ModernaTX on May 27 for "Branched tail lipid compounds and compositions for intracellular delivery of therapeutic agents" (Massachusetts Inventors)

ALEXANDRIA, Va., June 17 -- United States Patent no. 12,312,293, issued on May 27, was assigned to ModernaTX Inc. (Cambridge, Mass.).

"Branched tail lipid compounds and compositions for intracellular delivery of therapeutic agents" was invented by Kerry E. Benenato (Cambridge, Mass.), Mark Cornebise (Arlington, Mass.), Edward Hennessy (Cambridge, Mass.) and Ellalahewage S. Kumarasinghe (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure features novel lipids and compositions involving the same. Lipid nanoparticles (e.g., empty LNPs or loaded LNPs) include a novel lipid as well as additional lipids such as phospholipids, structural lipids, and PEG lipids. Lipid nanoparticles (e.g.,...